Skip to content

Trigeminal Neuralgia Electrophysiology

Trigeminal Evoked Responses to Improve Rhizotomy

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05269472
Enrollment
30
Registered
2022-03-08
Start date
2022-04-04
Completion date
2027-04-07
Last updated
2025-11-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Trigeminal Neuralgia

Keywords

Trigeminal Neuralgia

Brief summary

The study intervention is to perform standard somatosensory evoked responses limited to the face during rhizotomy procedures of the gasserian ganglion (trigeminal ganglion) for the treatment of trigeminal neuralgia. The evoked responses will be measured at two locations before and after the clinical rhizotomy including: the standard contralateral scalp (EEG) and at the gasserian ganglion through an FDA-approved recording electrode.

Interventions

PROCEDURETrigeminal Electrophysiology

This study will pilot and test the feasibility of introducing electrophysiology into the routine rhizotomy procedure by including trigeminal somatosensory evoked potentials (TSEPs) and recording from electrodes at the level of the ganglion.

Sponsors

University of Minnesota
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

(TGN): * Adults of 18 years or older * Scheduled to undergo percutaneous rhizotomy for facial pain

Exclusion criteria

(TGN): * Facial pain of unclear origin (i.e. not clearly TGN pain) * Rhizotomy procedure canceled Inclusion Criteria (Healthy controls) * Adults of 18 years or older

Design outcomes

Primary

MeasureTime frameDescription
Determine the feasibility of measuring trigeminal somatosensory evoked potentials to improve personalized mapping during percutaneous rhizotomy3 yearspercentage of consented participants who complete the study

Countries

United States

Contacts

Primary ContactMatthew Maple
maple036@umn.edu612-946-1424

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026